Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ellis

Showing results (161-170 of 252) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|April 20, 2005
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery diseaseAlexandra J Lansky, Ricardo A Costa, Michael Mooney, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trialsHiroshi Doi, Akiko Maehara, Gary S Mintz, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
The American Journal of Cardiology|April 22, 2005
Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study)S Chiu Wong, Mun K Hong, Stephen G Ellis, et al.
The American Journal of Cardiology|September 16, 2020
Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic ShockAnirudh Kumar, Chetan P Huded, Leon Zhou, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant deviceStefan Sack, Philipp Kahlert, Luc Bilodeau, et al.
Circulation|November 2, 2017
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized TrialsZiad A Ali, Runlin Gao, Takeshi Kimura, et al.
JAMA|September 15, 2005
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialGregg W Stone, Stephen G Ellis, Louis Cannon, et al.
JACC. Cardiovascular Interventions|January 15, 2025
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial ProgramDavid A Power, Anton Camaj, Dean J Kereiakes, et al.
Pageof 26

Showing results (161-170 of 252) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|April 20, 2005
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery diseaseAlexandra J Lansky, Ricardo A Costa, Michael Mooney, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trialsHiroshi Doi, Akiko Maehara, Gary S Mintz, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
The American Journal of Cardiology|April 22, 2005
Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study)S Chiu Wong, Mun K Hong, Stephen G Ellis, et al.
The American Journal of Cardiology|September 16, 2020
Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic ShockAnirudh Kumar, Chetan P Huded, Leon Zhou, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant deviceStefan Sack, Philipp Kahlert, Luc Bilodeau, et al.
Circulation|November 2, 2017
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized TrialsZiad A Ali, Runlin Gao, Takeshi Kimura, et al.
JAMA|September 15, 2005
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialGregg W Stone, Stephen G Ellis, Louis Cannon, et al.
JACC. Cardiovascular Interventions|January 15, 2025
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial ProgramDavid A Power, Anton Camaj, Dean J Kereiakes, et al.
Pageof 26